Nasal biopsy study for Alzheimer's and smell disorders
Part of Brain & nervous system, Mental health clinical trials.
This study takes a small tissue sample from inside your nose to look for changes linked to Alzheimer's disease or smell problems. It may help us better understand how these conditions affect the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can be between 18 and 80 years old for the Alzheimer's group, or 18 or older for the smell disorder group.
- You have either early Alzheimer's (with normal thinking but positive biomarker tests) or a confirmed Alzheimer's or dementia diagnosis, OR you have a smell disorder or are already having nasal surgery.
- You cannot be allergic to Afrin or tetracaine (numbing sprays used in the procedure).
- You do not have Parkinson's disease or active sinus or nasal problems that would make the biopsy unsafe.
- You can have a tiny camera look inside your nose and understand the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if steroid drops placed directly in the nose can improve smell in people with chronic sinusitis and a blocked smell area. It may help if you have had smell loss and sinus inflammation.
This trial uses remote, at-home (or remote) smell-based testing to help researchers assess health in people with preclinical Alzheimer’s disease and in control participants. It may help by showing how well smell-related changes can signal disease status over time.
This study looks at why people with nasal polyps lose their sense of smell and how it might come back. You may be able to join if you have had nasal blockage, runny nose, smell loss, or facial pain for at least 12 weeks, have polyps seen inside your nose, and are using a steroid spray regularly.
This study tests whether a daily smell training routine can help improve your sense of smell. It is open to adults with any kind of smell loss or problem, including those with conditions like COVID-19 or head injury, but not certain brain diseases.
This study looks at whether a specific brain protein (alpha-synuclein) is linked to other neurologic symptoms in people who have long-lasting smell loss. It may help researchers understand what causes smell loss and how it relates to later brain or nerve changes.
This study aims to create a simple scoring system to see how much of the smell area in your nose is blocked in people with chronic sinusitis and nasal polyps. It could help doctors better understand your condition and guide treatment.
Hear when a new Smell Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.